CIK 0001729427 · Non-accelerated filer<br>Smaller reporting company
CNS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CNSP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 822318545
- Phone
- 1-800-946-9185
- Business address
- 2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
- 10-K/A Report 10-K/A
- 4 Open-market buy Director bought 2,500 shares at $1.70 ($4,250)
- 4 Open-market buy Chief Financial Officer bought 3,100 shares at $3.20 ($9,920)
- 4 Open-market buy Director bought 7,173 shares at $0.74 ($5,308)
- 4 Open-market buy Chief Executive Officer bought 15,000 shares at $0.69 ($10,409)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-K Report Annual Report
- SC 13G Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Other events
- 424B4 Offering Prospectus
- 8-K Event Material agreement · Other events
- EFFECT Other Notice of Effectiveness
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
Page 12 of 20 · 390 filings